PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Update Il y a 4 ans
Reference: NCT00867815

Extract

The primary objective of this study is to determine whether the use of PDE5 inhibitors (vardenafil, sildenafil, or tadalafil) increases the risk for the development of NAION.


Inclusion criteria

  • Anterior Ischemic Optic Neuropathy


Links